Research Paper Volume 15, Issue 6 pp 2293—2307
Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma
Figure 7. Expression of the 12 genes in database and in vitro validation of EXO1. (A) Gene expression in GSE19188 and (B) GSE10072. Expression of EXO1 in different (C) recurrence subgroups, (D) tumor status, and (E) stages. (F) Relative expression of EXO1 in tumor and normal tissues of 5 patients in our center for RNA level. (G) Protein level of EXO1 in patients in our center, and barplot shows its relative expression. N represents normal tissue, and T for tumor tissues.